NL-OMON42213已完成不适用
The effect of cannabidiol (40mg) on fear conditioning - The effect of cannabidiol (40mg) on fear conditioning
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Male or female volunteers between 18 and 40 years.
- •- Judged to be in good physical and mental health on the basis of the
- •medical history according to self-report.
- •- Have a normal binocular acuity, corrected or uncorrected.
- •- Female participants must declare they are on reliable birth control.
排除标准
- •- Have a history of any disease, e.g. neurological disorders, psychiatric disorders, which in the opinion of the investigator may confound the results of the study.
- •- Present any other conditions in that in the investigators*, the subjects* personal or the physicians* opinion may confound the results of the study.
- •- History of psychotic disorder/psychosis and/or having a first/second degree family member with (a history of) psychotic disorder/psychosis.
- •- Current diagnosis of an Axis I or Axis II psychiatric disorder, or suffering from an Axis I or Axis II psychiatric disorder within 4 weeks prior to the study.
- •- Current respiratory disease or history of respiratory disease.
- •- Current asthma or history of asthma.
- •- Acute cardiac disease and/or history of cardiac disease.
- •- Known hypersensitivity to CBD.
- •- Exposed to cannabinoids with adverse reactions.
- •- Have a history of severe allergy or general drug hypersensitivity.
- •- History of abuse or current regular use of cannabis more than once a week.
- •- Have been using psychoactive drugs in the four weeks prior to the study.
- •- Current use of drugs of abuse or indications, from urine screening, of current use of drugs of abuse
- •- History of epilepsy.
- •- Pregnancy, i.e., a positive β-HCG urine test.
- •- Lactating.
- •- Reduced startle reactivity, defined as no discernable response in at least 3 out of the 12 startle stimuli presented at screening.
研究者
相似试验
已完成
不适用
The effect of cannabidiol in facilitating fear extinction and in attenuating fear retention and reinstatement in humansanxiety disorderspathological fear10002861NL-OMON46397niversiteit Utrecht56
尚未招募
不适用
The effect of cannabidiol (40mg) on fear conditioninganxiety disordersNL-OMON28165trecht University (UU)48
尚未招募
不适用
The effect of cannabidiol (300 mg) on fear conditioning.Anxiety, fear conditioningAngst, angstconditioneringNL-OMON28474trecht University56
已完成
不适用
The effect of Cannabidiol (CBD) on paranoid cognitions in humansParanoid cognitionsMental and Behavioural DisordersISRCTN11082858King's College London (UK)20
尚未招募
3 期
Evaluation of the effect of cannabidiol in the treatment of schizophrenic patientsSchizophrenia.SchizophreniaIRCT20210310050660N2Qazvin University of Medical Sciences40